Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2008
09/23/2008US7427471 Modified “S” antibodies
09/23/2008US7427470 Antisense modulation of helicase-moi expression
09/23/2008US7427404 immunologically active and having reduced or no toxicity; decreased histamine sensitivity activity
09/23/2008US7427403 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents
09/23/2008US7427396 genetic engineered adeno-associated virus (AAV) virions comprising a heterologous nucleiotide sequence that codes for therapeutic protein is selected from cystic fibrosis transmembrane conductance regulators, antitrypsin, superoxide dismutase, interleukins, interferons, p53, and retinoblastoma genes
09/23/2008US7427394 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic
09/23/2008US7427392 Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
09/23/2008CA2445687C Compositions, methods and systems for the discovery of enediyne natural products
09/23/2008CA2346797C Process for recovering heterologous polypeptides from bacterial cells
09/23/2008CA2335393C Liposomal encapsulated nucleic acid-complexes
09/23/2008CA2332126C A novel human thrombopoietin mutein
09/23/2008CA2294598C Transcriptional activators with graded transactivation potential
09/23/2008CA2290863C Plant transformation methods
09/23/2008CA2264967C Method of dna sequencing
09/23/2008CA2259940C High-affinity interleukin-4 muteins
09/23/2008CA2259179C Emulsion formulations for hydrophilic active agents
09/23/2008CA2219106C Nucleic acid ligands of tissue target
09/23/2008CA2195209C Use of rna polymerase to improve nucleic acid amplification process
09/23/2008CA2187283C Circularly permuted ligands and circularly permuted chimeric molecules
09/23/2008CA2186004C Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
09/23/2008CA2169852C Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics
09/23/2008CA2163256C Adenoviral vectors of animal origin and use thereof in gene therapy
09/23/2008CA2143125C Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
09/23/2008CA2139430C Polypeptides having serotoninergie activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof
09/23/2008CA2118373C Method to reverse the phenotype of transformed cells by the transcription factor irf-1
09/18/2008WO2008112970A2 Dominant gene suppression transgenes and methods of using same
09/18/2008WO2008112911A2 Attenuated reoviruses for selection of cell populations
09/18/2008WO2008112633A2 Method of meristem excision and transformation
09/18/2008WO2008112628A2 Preparation and use of plant embryo explants for transformation
09/18/2008WO2008112613A2 Manipulation of ammonium transporters (amts) to improve nitrogen use efficiency in higher plants
09/18/2008WO2008112542A1 Methods for conditional and inducible transgene expression to direct the development of stem cells
09/18/2008WO2008112514A1 He4 monoclonal antibodies and methods for their use
09/18/2008WO2008112475A2 Protein sweetener
09/18/2008WO2008112459A2 Alkaliphilic bacillus species a-amylase variants, compositions comprising a-amylase variants, and methods of use
09/18/2008WO2008112404A1 Deployable segmented tlif device
09/18/2008WO2008112297A2 Methods of treating cancer by interfering with igf-i receptor signaling
09/18/2008WO2008112290A2 Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer
09/18/2008WO2008112267A2 Transformation of immature soybean seeds through organogenesis
09/18/2008WO2008112218A2 Li-rnai involved li suppression in cancer immunotherapy
09/18/2008WO2008112030A2 Transfection in electronically driven continuous flow
09/18/2008WO2008112019A2 Maize event dp-098140-6 and compositions and methods for the identification and/or detection thereof
09/18/2008WO2008112008A2 Sensor proteins and assay methods
09/18/2008WO2008111981A1 Compositions, systems, and methods for preservation of macromolecules
09/18/2008WO2008111779A1 Antisense dna of sweetpopato expansin cdna and method for increasing storage root yield using the same
09/18/2008WO2008111708A1 L-threonine overproducing microorganism and method for preparing l-threonine using the same
09/18/2008WO2008111661A2 Method of expression of foreign gene in plant induced by chemical substance
09/18/2008WO2008111650A1 Dayflower flavonoid 3',5'-hydroxylase gene
09/18/2008WO2008111634A1 Biomarker specific to brain/nerve or specific to neuronal differentiation
09/18/2008WO2008111613A1 Endoglucanase ppce and cellulase preparation containing the same
09/18/2008WO2008111608A1 Novel hydrogen-producing bacterium
09/18/2008WO2008111507A1 Modified glucosamine-6-phosphate synthase
09/18/2008WO2008111506A1 Method of preparing transgenic cells
09/18/2008WO2008111485A1 Compound having structure derived from mononucleoside or mononucleotide, nucleic acid, labeling substance, and method and kit for detection of nucleic acid
09/18/2008WO2008111453A1 Method for amplification of dna fragment
09/18/2008WO2008111430A1 METHOD FOR PRODUCING γδT CELL POPULATION
09/18/2008WO2008111161A1 Method of identifying uniformity of mesenchymal stem cells and uniform mesenchymal stem cells isolated using the method
09/18/2008WO2008110876A1 Mutagenized tobacco plant as seed culture for the production of oil for energetic, industrial and alimentary uses
09/18/2008WO2008110848A2 Plant responses
09/18/2008WO2008110803A1 Somatotransgenic bioimaging
09/18/2008WO2008110653A1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof
09/18/2008WO2008110624A2 Sirna-mediated silencing of genes for treating chemotherapeutic drug-resistant epithelial tumors
09/18/2008WO2008110522A1 Use of nematode chitinase genes to control plant parasitic nematodes
09/18/2008WO2008110513A1 Thermostable asparaginases
09/18/2008WO2008110498A1 Solubilization of protease crystals in fermentation broth
09/18/2008WO2008110356A2 Protein pi 16 secreted from the heart and uses thereof
09/18/2008WO2008110332A1 Peptide-complement conjugates
09/18/2008WO2008110303A1 Novel gene useful for growth control of plants
09/18/2008WO2008110073A1 Improving cold- and salt-tolerant performance of plants with transcription factor gene snac2 from rice
09/18/2008WO2008110056A1 A vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof
09/18/2008WO2008110019A1 Clinical sample preparation on a microfluidic platform
09/18/2008WO2008110004A1 Reoviruses having modified sequences
09/18/2008WO2008109996A1 Assessing chemotherapy resistance of colorectal tumors by determining sparc hypermethylation
09/18/2008WO2008109976A1 Kunitz-type recombinant inhibitor
09/18/2008WO2008091375A9 Attenuated salmonella as a delivery system for sirna-based tumor therapy
09/18/2008WO2008090148A3 Improvement of cell growth
09/18/2008WO2008088849A3 Inflammation treatment, detection and monitoring via trem-1
09/18/2008WO2008085729A3 Resistance management strategies for transgenic crops
09/18/2008WO2008076437A3 Activin-actrii antagonists and uses for increasing red blood cell levels
09/18/2008WO2008073800A3 Acetolactate synthase herbicide resistant sorghum
09/18/2008WO2008071771A3 Inhibition of gpr4
09/18/2008WO2008070816A3 Staphylococcal two helix binding protein
09/18/2008WO2008057235A9 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes
09/18/2008WO2008057158A9 Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications
09/18/2008WO2008049865A3 Methods for increasing the resistance in plants to biotropic fungi
09/18/2008WO2008036970A3 Insulin-degrading enzyme mutants and methods of use
09/18/2008WO2008029276A8 Compositions and methods for the treatment of ophthalmic disease
09/18/2008WO2008027560A3 Holin-enhanced vaccines and reagents, and methods of use thereof
09/18/2008WO2007148091B1 Dna molecules and methods
09/18/2008WO2007143701A3 Monoclonal antibodies that potently neutralize hepatitis c virus (hcv) of diverse genotypes
09/18/2008WO2007047518A3 Polynucleotides encoding lignin biosynthetic pathway enzymes in coffee
09/18/2008US20080229457 S-adenosyl-l-methionine synthetase promoter and its use in expression of transgenic genes in plants
09/18/2008US20080229456 Recombinant DNA constructs and methods for controlling gene expression
09/18/2008US20080229455 Using vector transformation to generate plant with enhanced carbohydrate content; improving fruit sweetness
09/18/2008US20080229454 Method For The Production Of Gamma-Linolenic Acid And/Or Stearidonic Acid In Transgenic Brassicaceae And Linaceae
09/18/2008US20080229453 Expression vector comprising nucleotide sequences coding serine/threonine kinase for use in propagating transgenic planys with seeds comprising enhanced lipid and fatty acid storage
09/18/2008US20080229452 Sugar and lipid metabolism regulators in plants II
09/18/2008US20080229451 Expression of microbial proteins in plants for production of plants with improved properties
09/18/2008US20080229450 Using vector transformation to generate plants expressing isopentenyl transferase (IPT) and fatty acid desaturase (FAD) gene sequences for use generating tobacco with enhances storage stability and freeze resistance
09/18/2008US20080229449 Expression vector comprising nucleotide sequences coding insecticidal protein for use in propagating insect resistant crop plants; biological pest control
09/18/2008US20080229448 Transgenic plants comprising expression vector which confers drought, freeze, heat and disease resistance